NASDAQ Equity Snapshot
NEUP Weekly Equity Report
Neuphoria Therapeutics Inc
What the company does
Neuphoria Therapeutics Inc (Ticker: NEUP) is an innovative biotechnology company at the forefront of developing pioneering therapies for mental health disorders utilizing psychedelic compounds and cutting-edge drug delivery technologies. With a robust pipeline of preclinical candidates, Neuphoria is strategically positioned to address critical unmet needs in mental health care, reflecting the growing demand for effective treatment options in this sector. As a leader in the expanding psychedelic therapy market, Neuphoria presents a unique investment opportunity for institutional investors looking to capitalize on transformative trends in healthcare that have the potential to redefine the treatment landscape …
What the weekly tape is saying
NEUP closed the latest completed week at 4.37 USD. The 4-week return is -7.6% and the 12-week return is -5.2%. Trend Signal is active, Market Dynamics is 1.01. Setup signature: Risk-first tape with a 31/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 4.44 USD
- Vs Trend Line
- -1.7%
- Fair Value
- 6.08 USD
- Vs Fair Value
- -28.2%
- 52W High
- 21.40 USD
- 52W Low
- 3.65 USD
- Drawdown
- -79.6%
- Range Position
- 4.1%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 5 weeks
- 52W Active Weeks
- 20
- 52W Active Breadth
- 38.5%
- Sector Scope
- US Healthcare
- Sector Rank
- 733 of 1038
- Sector Percentile
- 29.4%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
US Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 0.8%
- Avg 4W
- 3.5%
- Trend Breadth
- 33.0%
- Positive MD
- 41.0%
US Biotechnology
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 4.9%
- Avg 4W
- 1.7%
- Trend Breadth
- 46.0%
- Positive RS
- 47.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 1.01
- 4W MD Change
- -6.8%
- Relative Strength
- -44.34
- 4W RS Change
- -7.4%
- Expectation
- Undecided
- Probability
- 53.95%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 308.0K
- 13W Average
- 245.5K
- 52W Average
- 2.1M
- Vs 13W
- 1.3x
- Vs 52W
- 0.1x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 8.4%
- 52W Volatility
- 16.8%
- Upside Weeks
- 26
- Downside Weeks
- 26
- Downside Breadth
- 50.0%
- Avg Gain / Loss
- 10.9% / -9.6%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NASDAQ
- Country
- US
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
- Market Cap
- 28.7M
Opportunity signals
- Trend Signal is active with a 5-week active streak.
- Market Dynamics is positive on the latest completed week.
Risk signals
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 4.37 USD | -2.7% | 4.44 USD | 6.08 USD | 1.01 | -44.34 | 308.0K | On |
| 5 Jun 2026 | 4.49 USD | -15.4% | 4.46 USD | 6.11 USD | 1.05 | -42.19 | 433.8K | On |
| 29 May 2026 | 5.31 USD | -3.1% | 4.44 USD | 6.13 USD | 1.22 | -35.47 | 106.9K | On |
| 22 May 2026 | 5.48 USD | 15.9% | 4.42 USD | 6.14 USD | 1.23 | -32.14 | 470.9K | On |
| 15 May 2026 | 4.73 USD | -10.9% | 4.44 USD | 6.15 USD | 1.08 | -41.29 | 169.8K | On |
| 8 May 2026 | 5.31 USD | 1.7% | 4.80 USD | 6.17 USD | 1.10 | -34.61 | 124.3K | Off |
| 1 May 2026 | 5.22 USD | 3.6% | 5.21 USD | 6.18 USD | 0.93 | -32.51 | 161.9K | Off |
| 24 Apr 2026 | 5.04 USD | 5.7% | 5.69 USD | 6.19 USD | 0.74 | -34.12 | 159.1K | Off |
| 17 Apr 2026 | 4.77 USD | -0.2% | 5.93 USD | 6.21 USD | 0.53 | -36.54 | 136.1K | Off |
| 10 Apr 2026 | 4.78 USD | 8.4% | 6.11 USD | 6.23 USD | 0.47 | -32.95 | 341.2K | Off |
| 2 Apr 2026 | 4.41 USD | 7.6% | 6.38 USD | 6.25 USD | 0.42 | -35.71 | 263.7K | Off |
| 27 Mar 2026 | 4.10 USD | -11.1% | 6.63 USD | 6.28 USD | 0.37 | -38.33 | 207.3K | Off |
| 20 Mar 2026 | 4.61 USD | 1.5% | 6.87 USD | 6.32 USD | 0.34 | -33.43 | 309.2K | Off |
| 13 Mar 2026 | 4.54 USD | 5.1% | 6.96 USD | 6.34 USD | 0.25 | -36.07 | 402.9K | Off |